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Abstract
Background: Myocardial delayed enhancement (MDE) by gadolinium-enhanced cardiac MRI is well established for
myocardial scar assessment in ischemic and non-ischemic heart disease. The role of MDE by cardiac CT (CT-MDE) is
not yet defined.
Findings: We reviewed all clinical cases of CT-MDE at a tertiary referral center to present the cases as a case series.
All clinical cardiac CT exams which utilized CT-MDE imaging between January 1, 2005 and October 1, 2010 were
collected as a series and their findings were also compared with available myocardial imaging to assess for
myocardial abnormalities, including echocardiography (wall motion, morphology), cardiac MRI (delayed
enhancement, morphology), SPECT MPI (perfusion defects). 5,860 clinical cardiac CT exams were performed during
the study period. CT-MDE was obtained in 18 patients and was reported to be present in 9 patients. The indications
for CT-MDE included ischemic and non-ischemic heart diseases. In segments positive for CT-MDE, there was
excellent agreement of CT with other modalities: echocardiography (n=8) demonstrated abnormal morphology
and wall motion (k=1.0 and k=0.82 respectively); prior MRI (n=2) demonstrated abnormal delayed enhancement
(MR-MDE) (k=1.0); SPECT MPI (n=1) demonstrated fixed perfusion defects (k=1.0). In the subset of patients without
CT-MDE, no abnormal segments were identified by echocardiography (n=8), MRI (n=1) and nuclear MPI (n=0).
Conclusions: CT-MDE was performed in rare clinical situations. The indications included both ischemic and
non-ischemic heart disease and there was an excellent agreement between CT-MDE and abnormal myocardium by
echocardiography, cardiac MRI, and nuclear MPI.
Findings
We reviewed all clinical cases of CT-MDE at a tertiary
referral center to present the cases as a case series. All
clinical cardiac CT exams which utilized CT-MDE
imaging between January 1, 2005 and October 1, 2010
were collected as a series and their findings were also
compared with available myocardial imaging to assess
for myocardial abnormalities, including echocardiog-
raphy (wall motion, morphology), cardiac MRI (delayed
enhancement, morphology), SPECT MPI (perfusion
defects) 5,860 clinical cardiac CT exams were performed
during the study period. CT-MDE was obtained in 18
patients and was reported to be present in 9 patients.
The indications for CT-MDE included ischemic and
non-ischemic heart diseases. In segments positive for
CT-MDE, there was excellent agreement of CT with
other modalities: echocardiography (n=8) demonstrated
abnormal morphology and wall motion (k=1.0 and
k=0.82 respectively); prior MRI (n=2) demonstrated
abnormal delayed enhancement (MR-MDE) (k=1.0);
SPECT MPI (n=1) demonstrated fixed perfusion defects
(k=1.0). In the subset of patients without CT-MDE, no
abnormal segments were identified by echocardiography
(n=8), MRI (n=1) and nuclear MPI (n=0).
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Cardiac magnetic resonance imaging (MRI) with gado-
linium can detect myocardial delayed enhancement
(MDE) [1] and has become the clinical imaging standard
for the evaluation of myocardial infarction and scar.
MDE is also useful in identifying myocardial injury and
in the assessment of infiltrative, inflammatory diseases
of the heart , ischemic heart disease and even in cardiac
neoplasm [2]. However, there are numerous contraindi-
cations to cardiac MRI, including severe claustrophobia,
several arrhythmias, metal implants and severe renal
insufficiency (a risk factor for nephrogenic systemic
fibrosis). In these patients, the clinical need for an alter-
native diagnostic tool for scar/injury imaging occasion-
ally arises.
Cardiac computed tomography (CT) can identify MDE
with iodinated contrast material because the pharmaco-
kinetics of iodinated agents are very similar to those of
gadolinium-DTPA [3,4]. Both agents are retained in
tissue with an increased volume of distribution including
myocardial infarction and scar. A number of studies are
underway to assess the role of cardiac CT using MDE.
In this report, we review our clinical experience where
CT-MDE was performed to yield insights into applica-
tion of this novel technique.
We retrospectively reviewed all clinical cases of CT-
MDE at a tertiary care referral center to present our
experience as a series of cases.
Methods
Study design
A waiver was obtained from our Institutional Review
Board (Partners Healthcare IRB) for this retrospective
study. All clinical cardiac CT exams performed from
January 1, 2005 to October 1, 2010 were included,
regardless of indication. Cases performed for research
purposes were excluded.
The text of all reports was screened for the use of a
delayed enhancement protocol. Reports were then
manually reviewed to refine the list to those patients
who underwent delayed imaging purely for the purpose
of MDE assessment. For example, early or immediate
delayed phase images obtained for thrombus detection
in the cardiac chambers were excluded (i.e. 2-minute
delayed scans for atrial appendage thrombus exclusion).
The cardiac CT images, reports and electronic records
were also reviewed for technique, technical parameters
(tube voltage, tube current, gating, timing, slice thick-
ness), radiation dose (dose length product as obtained
from the dose exposure record), and image quality (sub-
jective assessment as dictated by interpreting reader).
Images were analyzed to determine the contrast-to-noise
ratio using regions of interest in the abnormal myocar-
dium and the remote normal myocardium.
Using the AHA 17 segment model [5], myocardial
segments on CT images were then identified. To corrobor-
ate CT-MDE findings in patients, all cardiac imaging
modalities performed within a period of three months were
retrieved and reviewed. These included 2-dimensional
echocardiography, cardiac MRI, and single photon emis-
sion cardiac tomogram (SPECT) myocardial perfusion
imaging (MPI) scans. Clinical reports were reconciled into
standardized segmental readings by physicians with ap-
propriate training in cardiac CT and MRI (B.B.G & S.U.),
2-dimensional echocardiography (N.K.), and nuclear
imaging (S.U.).
Imaging methods
Cardiac CT was performed with 64-detector-row and
higher multidetector single- and dual-source scanners
(Somatom Sensation 64, Somatom Definition, and Soma-
tom Definition Flash; Siemens, Forchheim, Germany).
Standard parameters were set for arterial phase scans for
image acquisition as per clinical protocol. All scans were
performed using the timing bolus method to determine
contrast material transit time, usually with a 20 mL
standard test bolus dose of the contrast medium at 4-7
mL/second, followed by 20-40 mL of normal saline
flush. An intravenous bolus of contrast agent, tailored to
scan parameters, usually 60-90 mL (iopamidol 76% [370
mg of iodine per milliliter] Isovue; Bracco Diagnostics,
Princeton, New Jersey was administered by using a dual-
h e a dp o w e ri n j e c t o ra n dw a su s u a l l yf o l l o w e db y4 0m Lo f
normal saline at 4-7 mL / sec. Tube voltage and tube
current were varied according to the patient size and insti-
tutional protocols.
Additional contrast was given after the arterial phase
scan at a slow rate of up to 2 mL / second, usually
between 50 and 90 mL, for a total of approximately 150
mL. The amount, rate, and timing were determined on a
case-by-case basis by the supervising physician.
MDE acquisitions were performed after a variable period
of 5-10 minutes after the initial contrast administrations
(mean delay time 7.0 minutes), at physician discretion. To
minimize the radiation exposure and increase the myocar-
dial contrast, decreased tube voltage (100 kVp or 80 kVp)
and prospective ECG triggering were used for the delayed
acquisition in all patients.
Routine clinical 2-dimensional echocardiograms, SPECT-
MPI images, and cardiac MRI exams were acquired accor-
ding to standard institutional protocols.
Data analysis
Axial source CT images were transferred to a dedicated
image processing workstation (Osirix MD v 1.0.1,
Pixmeo, Bernex, Switzerland) for analysis. Cardiac CT
clinical reports and DICOM image headers were also
parsed for the technique, radiation dose, and indications.
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quality, and contrast to noise ratio in the areas of
delayed enhancement. The contrast-to-noise ratio of the
cardiac CT images was calculated as the signal intensity
difference between enhanced and remote myocardium
divided by the standard deviation of the signal intensity
(attenuation) within the remote normal myocardium [6].
Total effective dose was calculated as a product of the
dose-length product and a standard conversion coeffi-
cient for the chest (k=0.014 mSv/ [mGy*cm]) [7].
In cases where MDE was reported, myocardial seg-
ments on CT images were identified using the AHA 17-
segment model. The segments with increased signal
intensity on the delayed scan were identified as segments
with MDE. Wall motion of each segment was analyzed
and was visually graded as normal (0), hypokinetic (1),
or akinetic/dyskinetic (2) respectively by physicians with
appropriate training in cardiac CT (S.U. /B.B.G).
2-Dimensional echocardiograms (done within 3 months
of the CT scans) were then retrieved and analyzed at a
dedicated DICOM viewing workstation (Xcelera Philips,
Michigan). Using the standardized AHA 17 segment mo-
del, the wall motion of each segment was analyzed and
was visually graded as normal (0), hypokinetic (1), or
akinetic/dyskinetic (2) respectively by a physician with
American College of Cardiology level III training in echo-
cardiography (N.K.). The morphology of the segment
(abnormal wall thickness/abnormal echogenicity) was also
analyzed and recorded on a segmental basis.
Any previous or intercurrent cardiac MRI scans (per-
formed for any reason) were also retrieved to the image
processing workstation for analysis. The segments were
analyzed by physicians with appropriate training in
cardiac MRI (S.U., B.B.G.) for presence or absence of
MR-MDE.
SPECT-MPI images were retrieved to a dedicated
viewing workstation (Invia medical imaging solutions,
Corridor 4D, Michigan) and the images were analyzed
for presence or absence of fixed perfusion defects. Read-
ers of the various exams were blinded to the results of
the exams.
Statistical analysis
All continuous variables are presented as means +/-
standard deviations. Agreement between CT (abnormal
myocardial delayed enhancement, and separately abnor-
mal segmental wall motion abnormality) and echocar-
diogram (morphology and separately LV regional wall
motion) was calculated and mean kappa values were
determined (<0.20 = poor agreement; 0.21–0.40= fair;
0.41 -0.60 = good; 0.61-0.80 = very good; 0.81-1.0 = ex-
cellent agreement). Agreement between CT and MRI
with regard to presence of MDE was also calculated and
mean kappa values were determined using the same
scale. Agreement between CT and SPECT-MPI with
regards to presence of fixed perfusion defects was also
calculated and mean kappa values were determined
using the same scale. Statistical analysis was performed
using SPSS version 17 (SPSS Inc., Chicago, IL).
Results
Of the 5,860 total cardiac clinical CT exams performed
during the study period, an MDE protocol was per-
formed in 18 cases. The characteristics of the patient
population are contained in Table 1. The clinical indica-
tions for MDE protocol included assessment for the
presence or progression of myocardial scarring due to
ischemic heart disease (n=9), non-ischemic causes i.e.
infiltrative disease (n=3), non ischemic dilated cardiomy-
opathy (n=3), hypertrophic cardiomyopathy (n=2), and
prior surgery (n=1).
A summary of the findings in each patient, in the
segments with abnormal delayed enhancement on car-
diac CT as well as all other available modalities is listed
in Table 2.
MDE images were acquired at a mean of 6.6 +/- 3.1
minutes after a mean contrast dose of 147 +/-15 ml.
Decreased tube voltage was used in all patients (100
kVp, n=11, 80 kVp, n=7). The imaging parameters of the
MDE scans are summarized in Table 3. All CT-MDE
images were deemed interpretable and of diagnostic
quality by the clinical reader.
At the time of cardiac CT, patients had either a contra-
diction to MRI (n=15), or a prior suboptimal or unsuccess-
ful cardiac MRI (n=3) (Table 4). Nine of the 18 cases were
reported as positive for CT-MDE. Out of these nine
positive cases, CT scans were performed for assessment of
ischemic myocardial scar in five patients. Of the remaining
four positive cases, two were performed to assess suspected
Table 1 Demographics and baseline characteristics
(+CT MDE = positive delayed enhancement on CT,
-CT MDE = no delayed enhancement on CT)
All Positive CT MDE Negative CT MDE
Age (Years) 57 ± 17 61 ± 16 54 ± 17
Diabetes 2 1 1
Hypertension 11 6 5
Dyslipidemia 5 3 2
Medications
Statins 8 5 3
Aspirin 13 7 6
Beta Blockers 9 5 4
CAD 8 4 4
Smoking 4 3 1
Obesity 4 2 2
Revascularization 3 1 2
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tion in hypertrophic cardiomyopathy, and one for scar
identification in non-ischemic dilated cardiomyopathy.
All of the nine positive cases had echocardiograms
available for comparison, each of which was performed
within 12 weeks of the CT exam. Two patients had
previous cardiac MRIs (within 1 week and 12 weeks of
the CT) and one patient had additional SPECT-MPI
(within 1 week of the CT) for comparison.
In one patient, the wall motion assessment by cardiac
CT was not possible due to the use prospectively ECG-
triggered technique.
A total of 136 segments were analyzed for wall motion
abnormality; 32 of these segments were clinically in-
terpreted as positive for CT-MDE. The kappa statistics
for the agreement of wall motion abnormality between
Table 2 Correlation between the myocardial segments showing delayed enhancement on cardiac CT and at least one
other imaging modality i.e. TTE, SPECT, or cardiac MRI
Clinical indication Contraindication to a
Cardiac MRI at the time
of Cardiac CT
Myocardial segments with
Delayed enhancement
Comparative
imaging
modality
Myocardial segments on
comparative modality
1 CAD – Chest pain and
inconclusive cardiac
MRI. (MRI was not able
to predict the cause
of DE)
Anxiety causing
incomplete and
inconclusive Cardiac
exam
Inferior wall (Transmural) SPECT MRI SPECT - Fixed perfusion defect in the
inferior wall MRI – Delayed
enhancement in Inferior wall.
CTA – Obstructive disease in the
dominant RCA
2C M – Progression of
Sarcoidosis (new pacemaker
precluded followup MRI)
Permanent Pacemaker Lateral wall Apical LV wall
(Patchy foci)
MRI Lateral Apical left ventricular wall
(Patchy foci)
3 CAD – Assessment of
ischemic scar
Permanent Pacemaker Basal wall Mid lateral wall TTE Basal, lateral wall (severe hypokinesis)
Apical wall (Hyper-reflective/ Increased
echogenicity)
4C M – Hypertrophic
cardiomyopathy
and scar assessment
AICD Basal, Mid inferior, Inferolateral,
Anterolateral LV wall
TTE Asymmetric septal hypertrophy.
5 CAD – Scar mapping for
ventricular tachycardia
ablation
AICD Basal, Mid inferolateral wall TTE Basal Mid inferolateral wall
(Hyper-reflective/ increased
echogenicity)
6C M – Idiopathic
cardiomyopathy and
Worsening ventricular
arrhythmias.
AICD Mid to apical anterior,
Anteroseptal, Anterolateral
LV wall
TTE Apical (Akinesis) Anteroseptal (Akineis)
Anterolateral wall (Hypokinesis)
Septum and apex (Hyper-reflectivity/
Increased echogenicity)
7C M – HCM, recurrent
AICD shocks
AICD Mid myocardium in
anteroseptal Basal wall
TTE Marked asymmetric LV hypertrophy.
8C M – Progression
of Sarcoidosis
Permanent Subepicardial portion of
antero-septal mid ventricular
wall Mid myocardial basal,
Anteroseptal wall and
Sub endocardial mid
inferolateral wall.
TTE Mid myocardial wall (Hypokinesis)
Inferoposterior (Hyper-reflective/
increased echogenicity)
Pacemaker
9 CAD – Ventricular
tachycardia storm;
scar assessment
AICD Inferior wall and Basal to
apical LV, Anterior wall at
basal, mid ventricular level.
TTE Inferior, septal, apical (Akinesis) Inferior
and posterior wall. (Hyper-reflective/
increased echogenicity)
AICD = Automated Implantable Cardioverter Defibrillator, CAD = Coronary artery disease, CM = Cardiomyopathy, C-MRI = cardiac MRI, DE = Delayed enhancement,
HCM = Hypertrophic cardiomyopathy, LV = Left ventricle, PM = Pace maker, TTE = Transthoracic echocardiogram, VT = Ventricular Tachycardia.
Table 3 Imaging parameters
Tube voltage 100 kVp: 11 patients,
80 kVp: 7 patients
Tube Current (mAs) 669 +/- 229
Contrast amount (ml) 147 +/-15
Timing of Scan (minutes after injection) 6.6 +/- 3.1
Contrast to Noise ratio (CNR) 1.6 +/- 0.7
Effective radiation dose (mSv) 4.1+/- 2.6
Table 4 Shows patient distribution and indications
for the delayed enhancement with Cardiac CT
(AICD = Implantable cardiac defibrillator, MDE = Myocardial
Delayed Enhancement)
AICD / Pacemaker 8 5
Non diagnostic/ inconclusive cardiac MRI 1 2
Patient discomfort/Claustrophobia 0 1
Contrast contraindication (Gadolinium) 0 1
Total number of clinical CTA exams (January 1, 2000 to October 1, 2010)
n = 5,860. Excluded: Exams without delayed imaging (n=5763). Early delayed
imaging for thrombus detection (n=79). Patients with delayed scans n=8.
Positve MDE = 9 pateints. Negative MDE = 9 patients.
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mality by cardiac CT for all segments was 0.83 and the
kappa statistics for agreement of segments with abnor-
mal wall motion between 2-dimensional echocardiog-
raphy and segments with abnormal CT-MDE with
cardiac CT was 0.82 (Tables 5 and 6).
In the two cases positive for CT-MDE in which a prior
cardiac MRI was available, the kappa statistics for agree-
ment between the segments showing MDE with CT and
MRI was 1.0 (i.e. in both cases, the same segments were
positive for delayed enhancement on both exams)
(Figures 1 and 2).
In the single case for which SPECT-MPI was available,
there was a fixed perfusion defect in the same segments
in which the cardiac CT identified CT-MDE. The kappa
statistics for agreement between the segments of CT-
MDE and SPECT-MPI was therefore 1.0 (Figure 2).
In the cases reported as negative for CT-MDE (n=9),
each had concordant imaging and no abnormal seg-
ments were found by other imaging modalities.
Discussion
Cardiac MRI is the standard of reference for scar detec-
tion and myocardial characterization with late gadolinium
enhancement, also known as myocardial delayed enhance-
ment imaging (MR-MDE). However, numerous situations
arise in routine practice whereby cardiac MRI is contrain-
dicated, or not feasible. When the detection of myocardial
scar / injury is clinically relevant in these patients, a
cardiac CT-MDE protocol may offer a practical alterna-
tive. Our data demonstrates that while delayed imaging
for myocardial indications with cardiac CT in clinical
practice is requested infrequently, the presence of abnor-
mal delayed enhancement in myocardial segments with
cardiac CT has an excellent correlation with regional
abnormalities detected on other concurrent cardiac im-
aging exams.
To our knowledge, this is the largest series of clinical
cases imaged with CT-MDE for both ischemic and non-
ischemic causes. Although pathologic proof of scar or
other corresponding myocardial abnormalities was not
obtained, comparison of the abnormal segments by
other modalities (echocardiography, SPECT-MPI, and
cardiac MRI) demonstrated that in all cases, the myocar-
dial segments with positive MDE were abnormal by at
least one other imaging modality. This suggests that the
CT evidence of MDE was due to a true myocardial
abnormality. Several animal and human studies have
demonstrated that delayed CT imaging can identify
myocardial scar [8-10].
All patients referred for cardiac CT had a contraindi-
cation to MRI or an unsuccessful cardiac MR exam. All
modern CT scanners are capable of imaging the heart
and are widely available. However, several challenges
exist. MRI-MDE benefits from high contrast-to-noise
ratios, made possible by “nulling” of signal in the
normal, healthy myocardium at delayed image acquisi-
tion. The inability of CT to null normal myocardium
results in significantly lower CNR values on MDE
images with CT [5]. While the CNR values calculated in
our study are indeed low, the image quality was deemed
adequate and clinically interpretable in all cases. Also,
the use of radiation necessary for cardiac CT is a con-
cern. However, newer CT systems and consistent use of
existing dose reduction strategies can lower the radiation
dose per acquisition to sub-mSv levels [11,12].
The chief limitation of our study is the retrospective
design. Any analysis of clinical cases performed for va-
rious indications during a 5-year period will result in
heterogeneous scan techniques and equipment. Tube
voltage, tube current, and radiation doses were selected
according to the available scanner, patient body habitus,
heart rate, and the clinical indication. Despite these
variations, we found that the studies all had interpretable
image quality.
Another limitation of our study is a small number of
clinical patients in whom CT-MDE protocol was
performed. These scans were performed only as a last
resort to answer a difficult clinical question. Although
Table 5 Relative agreement of all segments between
64-slice MDCT and echocardiography scores
All segment Echocardiography score
n=136 0 1 2 Total
CT score 0 64 4 0 68
1 3 42 1 46
24 2 1 6 2 2
Total 71 48 17 136
Kappa = 0.83.
Wall motion by MDCT and echocardiography showed excellent agreement
(k=0.83).
Wall motion scores of 0 to 2 were assigned to the different segments.
0 = normal wall motion; 1 = hypokinesia; 2 = Akinesia, MDCT, multidetector CT.
Table 6 Relative agreement of CT DE positive only
segments between 64-slice MDCT and echocardiography
scores
D+segment Echocardiography score
n=136 0 1 2 Total
CT score 0 15 2 0 17
1 1 13 0 14
20 0 1 1
Total 16 15 1 32
Kappa = 0.82.
Wall motion by MDCT and echocardiography showed excellent agreement
(k=0.82).
Wall motion scores of 0 to 2 were assigned to the different segments.
0 = normal wall motion; 1 = hypokinesia; 2 = Akinesia. DE, delayed
enhancement, MDCT, multidetector CT.
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http://www.biomedcentral.com/1756-0500/6/2Figure 1 Panel A. 72 year old female with known sarcoidosis was found to have patchy areas of delayed hyper enhancement
(blue arrows) in the lateral wall of the left ventricle at cardiac MRI. Panel B. Three months after pacemaker placement which precluded
repeat MRI (green arrow), the patient developed symptoms warranting analysis for cardiac sarcoid progression. MDE by cardiac CT shows
corresponding patches of delayed hyperenhancement (red arrows) which confirmed stable involvement since the recent cardiac MRI.
Figure 2 A 56-year-old male with hyperlipidemia presented with atypical chest pain. Cardiac MRI demonstrated scar (abnormal delayed
enhancement--red arrows) in the entire inferior wall of the left ventricle as seen in two-chamber view (Panel A). CTA was performed to assess for
previously unsuspected coronary disease; delayed images were performed confirming the same inferior wall delayed enhancement as seen in the
two chamber and short-axis views (Panels B & C). The same patient underwent stress and rest Technitium-99m-Sestamibi SPECT- MPI (short axis
images obtained at stress-Panel D and rest-Panel E), which corroborated the fixed defect in the inferior wall.
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each case was an off-label use of contrast and a non-routine,
unproven utilization of cardiac CT.
If confirmed in large-scale studies, myocardial charac-
terization with delayed enhancement may eventually
become an accepted indication for cardiac CT. Validation
of this application of cardiac CTcould perhaps lead to the
development of comprehensive cardiac CT protocols
demonstrating coronary artery anatomy, ventricular func-
tion, and scar detection. This rich dataset could be
obtained in a single brief examination, facilitating diagno-
ses and guiding patient management [13,14]. Abnormal
delayed enhancement has been shown to provide incre-
mental diagnostic value to other cardiac MRI findings,
and cardiac CT with MDE imaging could bring this diag-
nostic benefit to an even greater number of patients [15].
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